The carriage of virulence factors in the commensal gut microbiota was associated with mortality in patients with alcoholic hepatitis, according to research presented at The Digital International Liver Congress.
Patients with primary biliary cholangitis who received bezafibrate after incomplete response to Ocaliva showed lower risk for death or liver transplant, according to a presenter at the Digital International Liver Congress.“Ursodeoxycholic acid [Ocaliva, Intercept] is a first-line treatment for primary biliary cholangitis. As you know, 20% to 30% of patients exhibit incomplete response to
Though absolute differences did not emerge in the treatment of hepatic encephalopathy with L-carnitine, a presenter at the Digital International Liver Congress suggested the changes seen indicate more research with higher doses may be warranted.“Twenty-four weeks of L-carnitine supplementation in covert hepatic encephalopathy patients did not improve quality of life,” Eileen Yoon, MD,
Thieme E-Books & E-Journals
Safe and possibly effective for alcohol cravings
Among patients with hepatocellular carcinoma who first failed Retevmo, Stivarga and Opdivo provided similar outcomes in terms of survival as second-line treatments, according to research presented at The Digital International Liver Congress.
In this exclusive video, Jasmohan S. Bajaj, MD, of Virginia Commonwealth University, discusses his study from the Digital International Liver Congress on fecal microbiota transplantation in the setting of alcohol use disorder.
The MELD score is used in the Eurotransplant (ET) region to allocate liver grafts. Hyponatremia in cirrhotic patients is an important predictor of death but is not incorporated in MELD. This study in…